MeVis Medical Solutions AG

Transaction in Own Shares • Jun 17, 2008

News Details

Ad-hoc | 17 June 2008 10:10

MeVis Medical Solutions completing stock buy-back program

MeVis Medical Solutions AG / Share Buyback

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

MeVis Medical Solutions completing stock buy-back program

Bremen, June 17, 2008. Bremen-based MeVis Medical Solutions AG [ISIN
DE000A0LBFE4], a specialist in disease-oriented software products for
image-based medicine, today completed its stock buy-back program following
the achievement of the five percent target.

Under a resolution passed at the annual general meeting on September 28,
2007, the Com-pany is authorized to buy back up to ten percent of its own
current share capital in accordance with Section 71 (1) No. 8 of the German
Stock Corporations Act. As MeVis Medical Solutions already held 37,800
treasury shares at the commencement of its buy-back program, the
Management Board decided on March 4, 2008 to initially buy back a further
53,200 of the Com-pany’s shares by August 30, 2008 via the stock exchange.
Under this stock buy-back program, the Company has acquired 53,200 of its
own shares as of today’s date, equivalent to a total of € 1,502,589. All
the stock was bought via the Xetra electronic trading platform and on the
floor of the Frankfurt stock exchange via the Company's designated sponsor
M.M. War-burg. As a result, MeVis Medical Solutions AG’s treasury stock
comprises a total of 91,000 shares, equivalent to five percent of its
current share capital.

By buying back its own stock, the Company wants to gain additional
strategic scope for acquisitions, the purchase of intellectual property,
investments and similar transactions aimed at implementing its growth
strategy. However, there are no specific plans for the utilization of the
treasury stock at this stage. In view of the recent recovery in the price
of MeVis stock, the Company’s Management Board has now decided against
buying back any further shares for now.

Detailed information on the progress of the stock buy-back program to date
in accordance with Art. 4 (3) and (4) of Commission Regulation (EC) No
2273/2003 of December 22, 2003 as regards exemptions for buy-back programs
and stabilization of financial instruments in con-nection with Article 20
(1) of Council Directive 93/22/EEC of May 10, 1993 on investment ser-vices
in the securities field is available at the Company’s website at
www.mevis.de.

---

Information and Explaination of the Issuer to this News:

MeVis Medical Solutions AG is one of the world’s leading independent
producers of software products for medical-imaging technology, particularly
digital radiology. Over the past few years, there has been an enormous
increase in the complexity and volume of medical image data derived from
imaging modalities such as computer tomography (CT) and magnet resonance
tomography (MRT). MeVis products analyze and process this data in such a
way as to provide medical practitioners with crucial information on the
diseases and organs in question for early detection, diagnosis and
intervention in the areas of oncology, neurology and surgery. The Company
develops its software solutions in close cooperation with medical experts
worldwide, and with the world’s leading original equipment manufacturers
(OEMs) in the medical technology sector and primarily markets this software
via these OEM part-nerships.

Company contact:
MeVis Medical Solutions AG
Dr. Kai Holtmann
Tel: +49 421 22495-63
E-mail: kai.holtmann@mevis.de

Press contact:
HOSCHKE & CONSORTEN Public Relations GmbH
Fabian Lorenz, Grit Pauli
Tel: +49 40 3690 50-56 / -31
E-mail: f.lorenz@hoschke.de; g.pauli@hoschke.de

17.06.2008 Financial News transmitted by DGAP

Language: English
Issuer: MeVis Medical Solutions AG
Universitätsallee 29
28359 Bremen
Deutschland
Phone: +49 421 330 74-0
Fax: +49 421 330 74-50
E-mail: office.mms@mevis.de
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Stuttgart, München, Düsseldorf

End of News DGAP News-Service

---